Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | BCL2L1 | Q07817 | 5/20 | 0.52 |
| ▸ | MCL1 | Q07820 | 5/20 | 0.52 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 2/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7076437 | 0.92 | MEN1 (0.56) | MAPTMEN1KMT2ALMNABCL2L1 | |
| SCHEMBL7052824 | 0.89 | SMPD1 (0.62) | MEN1KMT2ABCL2L1MCL1SMPD1 | |
| SCHEMBL7045604 | 0.88 | SMPD1 (0.61) | MEN1KMT2ABCL2L1MCL1SMPD1 | |
| SCHEMBL7080413 | 0.86 | MYC (0.55) | MAPTMEN1KMT2ALMNABCL2L1 | |
| SCHEMBL7049348 | 0.86 | MAOB (0.60) | MAPTMEN1KMT2ALMNABCL2L1 | |
| SCHEMBL7077932 | 0.85 | HDAC1 (0.58) | MEN1KMT2ABCL2L1MCL1SMPD1 | |
| SCHEMBL7083454 | 0.85 | SMPD1 (0.54) | MEN1KMT2ABCL2L1MCL1SMPD1 | |
| SCHEMBL7076910 | 0.85 | HDAC1 (0.59) | MEN1KMT2ABCL2L1MCL1SMPD1 | |
| SCHEMBL7082518 | 0.84 | SMPD1 (0.54) | MEN1KMT2ABCL2L1MCL1SMPD1 | |
| SCHEMBL7080625 | 0.83 | BCL2L1 (0.59) | MEN1KMT2ABCL2L1MCL1SMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030162818-A1 | Acylsulfonamide derivative | AJINOMOTO CO. INC. (JP) | 2003-08-28 | — | — | US | disclosed |
| US-6555584-B1 | Acetyl-coa carboxylase inhibitors | AJINOMOTO CO., INC. (JP) | 2003-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162818-A1 | Acylsulfonamide derivative | ACSS2, ACACA, FASN | MAPT 3922/4885MEN1 4502/4885KMT2A 934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.